Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
35492 | 96 | 37.4 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
919 | 2 | PD L1//PD 1//FOXP3 | 11160 |
35492 | 1 | LAG 3//LYMPHOCYTE ACTIVATION GENE 3//CD223 | 96 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LAG 3 | authKW | 2626411 | 18% | 49% | 17 |
2 | LYMPHOCYTE ACTIVATION GENE 3 | authKW | 1454071 | 8% | 57% | 8 |
3 | CD223 | authKW | 1431355 | 6% | 75% | 6 |
4 | SOLUBLE LAG 3 | authKW | 636159 | 2% | 100% | 2 |
5 | LAG3 | authKW | 508922 | 4% | 40% | 4 |
6 | ACTIVATION GENE | authKW | 318080 | 1% | 100% | 1 |
7 | ACTIVATORY RECEPTORS | authKW | 318080 | 1% | 100% | 1 |
8 | CANCER CHECKPOINTS | authKW | 318080 | 1% | 100% | 1 |
9 | CD1D RESTRICTED NKT CELL | authKW | 318080 | 1% | 100% | 1 |
10 | CHILDREN HEMATOL CHEMIOTHER Y | address | 318080 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 2101 | 70% | 0% | 67 |
2 | Oncology | 81 | 17% | 0% | 16 |
3 | Medicine, Research & Experimental | 48 | 9% | 0% | 9 |
4 | Cell Biology | 15 | 8% | 0% | 8 |
5 | Genetics & Heredity | 8 | 5% | 0% | 5 |
6 | Allergy | 3 | 1% | 0% | 1 |
7 | Rheumatology | 2 | 1% | 0% | 1 |
8 | Reproductive Biology | 1 | 1% | 0% | 1 |
9 | Transplantation | 1 | 1% | 0% | 1 |
10 | Virology | 0 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHILDREN HEMATOL CHEMIOTHER Y | 318080 | 1% | 100% | 1 |
2 | DIABET IMMUNOGENET PEDIAT | 318080 | 1% | 100% | 1 |
3 | EA 3545 | 318080 | 1% | 100% | 1 |
4 | FONDAZ RIC CURA CARATTERE SCI | 318080 | 1% | 100% | 1 |
5 | HPUMRS976 | 318080 | 1% | 100% | 1 |
6 | HPUNITE MIXTE RECH SCI 940 | 318080 | 1% | 100% | 1 |
7 | ITUNUMR643 | 318080 | 1% | 100% | 1 |
8 | MBARARA UNIV SCI TECHNOLMED | 318080 | 1% | 100% | 1 |
9 | TECHNOL ACQUISIT | 318080 | 1% | 100% | 1 |
10 | UMR643ITERT | 318080 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF IMMUNOLOGY | 1960 | 9% | 0% | 9 |
2 | JOURNAL OF IMMUNOLOGY | 1931 | 19% | 0% | 18 |
3 | ONCOIMMUNOLOGY | 1328 | 2% | 0% | 2 |
4 | INTERNATIONAL IMMUNOLOGY | 1264 | 4% | 0% | 4 |
5 | IMMUNOGENETICS | 639 | 3% | 0% | 3 |
6 | EUROPEAN JOURNAL OF IMMUNOGENETICS | 564 | 1% | 0% | 1 |
7 | JOURNAL OF TRANSLATIONAL MEDICINE | 547 | 2% | 0% | 2 |
8 | CANCER SCIENCE | 358 | 2% | 0% | 2 |
9 | EXPERT REVIEW OF VACCINES | 254 | 1% | 0% | 1 |
10 | TRENDS IN IMMUNOLOGY | 245 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LAG 3 | 2626411 | 18% | 49% | 17 | Search LAG+3 | Search LAG+3 |
2 | LYMPHOCYTE ACTIVATION GENE 3 | 1454071 | 8% | 57% | 8 | Search LYMPHOCYTE+ACTIVATION+GENE+3 | Search LYMPHOCYTE+ACTIVATION+GENE+3 |
3 | CD223 | 1431355 | 6% | 75% | 6 | Search CD223 | Search CD223 |
4 | SOLUBLE LAG 3 | 636159 | 2% | 100% | 2 | Search SOLUBLE+LAG+3 | Search SOLUBLE+LAG+3 |
5 | LAG3 | 508922 | 4% | 40% | 4 | Search LAG3 | Search LAG3 |
6 | ACTIVATION GENE | 318080 | 1% | 100% | 1 | Search ACTIVATION+GENE | Search ACTIVATION+GENE |
7 | ACTIVATORY RECEPTORS | 318080 | 1% | 100% | 1 | Search ACTIVATORY+RECEPTORS | Search ACTIVATORY+RECEPTORS |
8 | CANCER CHECKPOINTS | 318080 | 1% | 100% | 1 | Search CANCER+CHECKPOINTS | Search CANCER+CHECKPOINTS |
9 | CD1D RESTRICTED NKT CELL | 318080 | 1% | 100% | 1 | Search CD1D+RESTRICTED+NKT+CELL | Search CD1D+RESTRICTED+NKT+CELL |
10 | CYTOTOYIC ANTIBODIES | 318080 | 1% | 100% | 1 | Search CYTOTOYIC+ANTIBODIES | Search CYTOTOYIC+ANTIBODIES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SIERRO, S , ROMERO, P , SPEISER, DE , (2011) THE CD4-LIKE MOLECULE LAG-3, BIOLOGY AND THERAPEUTIC APPLICATIONS.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 15. ISSUE 1. P. 91 -101 | 34 | 61% | 36 |
2 | GOLDBERG, MV , DRAKE, CG , (2011) LAG-3 IN CANCER IMMUNOTHERAPY.CANCER IMMUNOLOGY AND IMMUNOTHERAPY. VOL. 344. ISSUE . P. 269 -278 | 26 | 62% | 46 |
3 | HE, YY , RIVARD, CJ , ROZEBOOM, L , YU, H , ELLISON, K , KOWALEWSKI, A , ZHOU, CC , HIRSCH, FR , (2016) LYMPHOCYTE-ACTIVATION GENE-3, AN IMPORTANT IMMUNE CHECKPOINT IN CANCER.CANCER SCIENCE. VOL. 107. ISSUE 9. P. 1193 -1197 | 34 | 49% | 0 |
4 | KISIELOW, M , KISIELOW, J , CAPOFERRI-SOLLAMI, G , KARJALAINEN, K , (2005) EXPRESSION OF LYMPHOCYTE ACTIVATION GENE 3 (LAG-3) ON B CELLS IS INDUCED BY T CELLS.EUROPEAN JOURNAL OF IMMUNOLOGY. VOL. 35. ISSUE 7. P. 2081-2088 | 23 | 77% | 43 |
5 | COOK, KD , WHITMIRE, JK , (2016) LAG-3 CONFERS A COMPETITIVE DISADVANTAGE UPON ANTIVIRAL CD8(+) T CELL RESPONSES.JOURNAL OF IMMUNOLOGY. VOL. 197. ISSUE 1. P. 119 -127 | 20 | 51% | 0 |
6 | TRIEBEL, F , (2003) LAG-3: A REGULATOR OF T-CELL AND DC RESPONSES AND ITS USE IN THERAPEUTIC VACCINATION.TRENDS IN IMMUNOLOGY. VOL. 24. ISSUE 12. P. 619-622 | 17 | 71% | 50 |
7 | LI, NY , WORKMAN, CJ , MARTIN, SM , VIGNALI, DAA , (2004) BIOCHEMICAL ANALYSIS OF THE REGULATORY T CELL PROTEIN LYMPHOCYTE ACTIVATION GENE-3 (LAG-3; CD223).JOURNAL OF IMMUNOLOGY. VOL. 173. ISSUE 11. P. 6806 -6812 | 17 | 71% | 25 |
8 | LI, XD , HU, WW , ZHENG, X , ZHANG, C , DU, P , ZHENG, ZJ , YANG, Y , WU, J , JI, M , JIANG, JT , ET AL (2015) EMERGING IMMUNE CHECKPOINTS FOR CANCER THERAPY.ACTA ONCOLOGICA. VOL. 54. ISSUE 10. P. 1706 -1713 | 28 | 29% | 5 |
9 | KIM, SS , KIM, SH , KANG, HS , CHUNG, HY , CHOI, I , CHEON, YP , LEE, KH , LEE, DM , PARK, J , LEE, SY , ET AL (2010) MOLECULAR CLONING AND EXPRESSION ANALYSIS OF PIG LYMPHOCYTE ACTIVATION GENE-3 (LAG-3; CD223).VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. VOL. 133. ISSUE 1. P. 72 -79 | 12 | 80% | 4 |
10 | BRIGNONE, C , GRYGAR, C , MARCU, M , SCHAKEL, K , TRIEBEL, F , (2007) A SOLUBLE FORM OF LYMPHOCYTE ACTIVATION GENE-3 (IMP321) INDUCES ACTIVATION OF A LARGE RANGE OF HUMAN EFFECTOR CYTOTOXIC CELLS.JOURNAL OF IMMUNOLOGY. VOL. 179. ISSUE 6. P. 4202-4211 | 19 | 53% | 11 |
Classes with closest relation at Level 1 |